Clotting Flashcards

1
Q

describe Virchow’s triad

A

three key factors that cause venous thrombosis

  1. venous stasis- occurs when the valves are dysfunctional or the muscles of the extremities are inactive
  2. damage of the endothelium (inner lining of the vein- may be caused by direct (e.g., surgery, intravascular catheterization, trauma, burns, prior VTE) or indirect (chemotherapy, diabetes, sepsis) injury. Stimulates platelet activation and starts coagulation cascade
  3. hypercoagulability of the blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe the pathophysiology of clot formations

A

Localized platelet aggregation and fibrin entrap RBCs, WBCs, and more platelets to form a thrombus. A frequent site of thrombus formation is the valve cusps of veins, where venous stasis occurs. As a thrombus enlarges, increased numbers of blood cells and fibrin collect behind it. This makes a larger clot with a “tail” that eventually blocks the lumen of the vein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define hemostasis

A

describes the arrest of bleeding
importnat in minimizing blood loss when various body structures are injured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

list the sequence of events of hemostasis

A
  1. vascular injury and subendothelial exposure
    • blood vessel injury –> vasoconstriction to reduce leakage of blood
  2. adhesion
    • platelets adhere to exposed adhesive glycoproteins
  3. activation
    -activation of platelets (they change shape). platelets bind to protein and more
  4. aggregation
    • platelet aggregation form fibrin clot.
  5. platelet plug formation
    • The final blood clot is a meshwork of protein strands that stabilizes the platelet plug and traps other cells, such as RBCs, phagocytes, and microorganisms.
  6. clot retraction and dissolution
    • This counter mechanism to blood clotting keeps blood in its fluid state.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the components of the hematologic system?

A

*RBCs, WBCs, Platelets
*Red Bone Marrow
*Spleen
*Lymph System
*Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the primary function of red blood cells (erythrocytes) is ___________

A

transport of gases and maintaining acid-base balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

define erythropoiesis

A

the making of red blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

erythropoiesis is stimulated by ______
a. the heart
b. hypoxia
c. hypertension
d. the liver

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which organ monitors the level of oxygen in the blood?

A

kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what happens when the kidney senses low oxygen levels?

A

secretes a hormone called erythropoietin (EPO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what happens when the kidney senses a high level of oxygen in the blood?

A

it stimulates bone marrow to produce RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

erythropoiesis is influenced by: SELECT ALL THAT APPLY

a. nutrient availability
b. liver function
c. brain activity
d. renal function

A

a & d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the normal lab value for hemoglobin

A

adult male: 14-18 g/dl
adult female: 12-16 g/dl
pregnant women: >11 g/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the normal lab values for hematocrit?

A

adult male: 42-52
adult female: 37-47
pregnant women: >33%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

list some clotting assessments

A
  • patient history
    • medications
    • surgery
    • nutrition
    • activity/exercise
    • sexuality/reproduction
  • Physical
    • skin
    • mouth and nose
    • musculoskeletal
    • cardiovascular/ pulmonary
  • abnormal bleeding
  • prolonged sitting
  • afib history
  • swelling/ pain in extremities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clotting lab tests

A

*PT (11.0-12.5 seconds)
- warfarin: 1.5-2.5
*INR (normal values vary)
*PTT (60-70 seconds)
*fibrinogen (200-400 mg/dl)
- level of fibrinogen
- increase = hypercoaguable
* platelet count (150,000-400,000)
*d-dimer
- measures fibrin fragments from clot lysis
- increase = hypercoagulable state
*erythrocyte count, hemoglobin, and hematocrit
*bone marrow examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

clotting radiologic tests

A
  • noninvasive venous studies: ultrasound used as a noninvasive approach for evaluation for venous thrombosis
  • arteriograms: allow for visualization of arteries by injecting radiopaque contrast into them so that the location and extent of occlusion or dilation can be identified
  • venograms: venograms of lower extremities allow visualization of veins by injecting radiopaque contrast into them so that the location and extent of thrombi can be identified
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Newborns have a ______ RBC, HGB, HCT that ____ slowly over the first month

a. decreased; increase
b. increased; increase
c. increased; decrease
d. decreased; decrease

A

C
* fetal circulation is less efficient at oxygen exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

infants have a ____ WBC

a. decreased
b. increased

A

b. increased
*risk for infection
*neutrophils unable to recognize foreign substances and mount a defense

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

infants have the same amount of platelets as adults

True or false?

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

pregnancy causes an (increase or decrease)

___ total blood volume
___blood coagulation
___plasma volume
___RBC volume
___HGB
___HCT
___clotting factors
___WBC
___granulocytes
___fibrinolytic activity
___risk of bleeding
___risk of thrombus

A

increased total blood volume
increased blood coagulation
increased plasma volume
increased RBC volume
decrease HGB
decrease HCT
increase clotting factors
increase WBC
increase granulocytes
decrease fibrinolytic activity
decreased risk of bleeding
increased risk of thrombus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

older adults are at greater risk for _______ because of their diminished ability to compensate for acute or chronic illness

A

infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

older adults lab values (increase, decrease, unaffected)
____Hgb
____WBC
____lymphocyte function
____platelets
____platelet adhesion

A

decreased Hgb
unaffected WBC
decreased lymphocyte function
unaffected platelets
increased platelet adhesion

24
Q

define venous thrombosis

A

formation of a thrombus (blood clot) with vein inflammation

25
Q

what is the difference between a superficial vein and a deep vein thrombosis

A

superficial vein thrombosis is the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein.

Deep vein thrombosis (DVT) involves a thrombus in a deep vein, most often the iliac and/or femoral veins.

26
Q

superficial vein thrombosis symptoms, how is it diagnosed, and treatment options

A
  • Firm, cordlike vein that can be palpated
  • Red, itchy, painful, warm, edematous
  • Collaborative care
  • Diagnosed with ultrasound
  • NSAIDs for symptom management
  • Warm compresses
  • Compression
  • Elevate or mild exercise
27
Q

venous thromboembolism symptoms

A

Pain
Edema
Tenderness with palpation
Sense of fullness in thigh or calf
Warm skin
Fever
Paresthesia

28
Q

VTE complication

A
  • pulmonary embolus: blood clot in lung
  • post-thrombotic syndrome: chronic condition
  • phlegmasia cerulea dolens: rare, swollen blue painful leg
29
Q

how is a VTE diagnosed?

A
  • history and physical exam
    • risk factors
    • subjective and objective symptoms
  • diagnostic studies
    • labs: CBC, clotting studies, D-dime
  • tests
    • ultrasound of extremity
30
Q

VTE nursing interventions (prevention and treatment)

A
  • Early and aggressive mobilization
  • Graduated Compression stockings (TEDs)
  • Intermittent Pneumatic Compression Devices (IPCs)
  • Administer anti-coagulant drugs (Table37.10) and monitor for effectiveness
  • Prophylaxis
  • Treatment
31
Q

warfarin is a

a. vitamin K antagonist
b. indirect thrombin inhibitor
c. direct thrombin inhibitor
d. factor Xa inhibitor

A

a

32
Q

which lab value do you monitor for warfarin?

A

monitor INR for therapeutic range

33
Q

warfarin patient teaching

A

bleeding risk, INR monitpring, interaction with other drugs (NSAIDs)/ herbals, dietary intake of vitamin K (green leafy)

34
Q

warfarin is a ____ medication

a. subcutaneous
b. PO
c. intramuscular
d. intravenous

A

b. PO

35
Q

what is the antidote for warfarin?

A

vitamin K

36
Q

Heparin sodium can be administered via IV for ____ treatment

A

VTE

37
Q

which lab values should be monitored for heparin?

A

aPTT or anti-Xa to titrate infusion rate

38
Q

heparin can be administered via subcutaneous injection for ______ or _____ of warfarin

A

prophylaxis or bridging

39
Q

______ reverses the effect of heparin

A

protamine sulfate

40
Q

a long term side effect of subcutaneous heparin infection is _____

A

osteoporosis

41
Q

when a patient is on heparin, the nurse should monitor for _____

A

Monitor for Heparin-inducedthrombocytopenia(HIT)
* Immune reaction to Heparin
* Sudden drop in platelet count

42
Q

low molecular weight heparin (LMWH) is also known as

A

enoxaparin

43
Q

enoxaparin is a ____

a. vitamin K antagonist
b. indirect thrombin inhibitor
c. direct thrombin inhibitor
d. factor Xa inhibitor

A

b

44
Q

enoxaparin is administered subcutaneously for ____________

A

prophylaxis or briding of warfarin

45
Q

why would enoxaparin be used instead of heparin?

A

*enoxaparin has a longer half-life than heparin
* fewer bleeding complications
* less likely to cause HIT and osteoporosis
* no ongoing lab monitoring

46
Q

________ neutralizes the effects of Low-molecular-weight heparin (LMWH)

A

protamine

47
Q

name the direct thrombin inhibitor anti-coagulants

A
  • bivalirudin
  • argatroban IV
  • dabigatran
48
Q

bivalirudin or argatroban IV is used for ____ patients during ____ with a history of ____

A

cardiac; PCI; HIT

49
Q

Dabigatran (PO) is used for patients with a history of ______, _____, or ____

A

HIT, VTE prevention with joint surgery, or afib

  • has a rapid onset, no labs, few drug-food interactions, lower bleeding risk, predictable dosing
50
Q

name the factor xa inhibitor that is given subcutaneously

A

fondaparinux

51
Q

name the factor xa inhibitors given PO

A

rivaroxaban, apixaban, betrixaban, endoxaban

52
Q

factor xa inhibitors are given for ____ treatment and __________

A

VTE; prophylaxis

53
Q

factor Xa inhibitors are contraindicated in patients with

a. severe liver disease
b. cardiovascular disease
c. VTEs
d. severe renal disease

A

d. severe renal disease

54
Q

name some medical interventions for VTE

A

*Thrombolytic infusion
-Cather infusion of thrombolytic agent (like tissue plasminogen activator—tPA (Alteplase) at site of thrombus

  • Thrombectomy
    -Surgical removal of clot

*Inferior Vena Cava (IVC) Filter Placement
-Catches clots before they travel

55
Q

list some ways to prevent VTE

A

avoid restrictive clothing, moderate exercise, moving legs and feet on long car and plane trips, compression stockings

56
Q

anticoagulant precautions

A
  • wear a medic alert identification if on anticoagulants
  • if on warfarin: watch for signs of bleeding, avoid falls, use a soft toothbrush, use an electric razor, hold pressure on cuts or punctures for 10-15 minutes, can monitor INR at home